We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Pregnancy Risks Reflected in Updated Antipsychotics Labeling
Pregnancy Risks Reflected in Updated Antipsychotics Labeling
February 25, 2011
The FDA has updated the labeling of antipsychotic drugs to reflect potential risks in newborns whose mothers are being treated with those drugs.
